Skip to main content
Keeps Biopharma Inc. logo

Keeps Biopharma Inc. — Investor Relations & Filings

Ticker · 256940 ISIN · KR7256940008 KO Manufacturing
Open in API
Filings indexed 290 across all filing types
Latest filing 2022-08-12 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 256940

About Keeps Biopharma Inc.

http://kpscorp.co.kr/

Keeps Biopharma Inc. is a company with operations in both manufacturing and biopharmaceuticals. Its manufacturing activities include the production of equipment for semiconductors and flat panel displays, such as organic light-emitting diodes (OLEDs), as well as cleanroom consumables. Concurrently, the company is expanding its biopharmaceutical business through research and development. Its strategic focus is on building a therapeutic pipeline centered on oncology and metabolic diseases, which includes the development of novel anticancer drugs and combination therapies.

Recent filings

Filing Released Lang Actions
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '(주)케이피에스' covering the period from 2022-01-01 to 2022-06-30. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-12 Korean
[기재정정]단일판매ㆍ공급계약체결(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details a correction (정정신고) to a previously filed contract, specifically updating the delivery date. Since this is a specific regulatory disclosure regarding a commercial contract and does not fit into categories like M&A, financial reports, or shareholder meetings, it falls under the general regulatory filing category.
2022-07-21 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding the adjustment of the conversion price (Refixing) for convertible bonds issued by KPS. This type of disclosure is a standard corporate action related to capital structure and debt instruments, which falls under the 'Capital/Financing Update' category.
2022-07-13 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '(주)케이피에스' (KPS Corporation) covering the period from 2022-01-01 to 2022-03-31. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2022
2022-05-13 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required when an individual or entity crosses a specific ownership threshold in a company. This document details the shareholding changes of Song Jun-ho and his special related parties in KPS (케이피에스). It includes tables for shareholding status, changes in ownership, and specific transaction details. This falls under the 'Major Shareholding Notification' category.
2022-04-01 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, including major shareholding notifications, changes in special relationships, and stock collateral agreements. This falls under the 'Major Shareholding Notification' category.
2022-03-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.